Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, China.
Sensors (Basel). 2014 Feb 19;14(2):3284-92. doi: 10.3390/s140203284.
The simplicity and sensitivity of the bimolecular fluorescence complementation (BiFC) assay make it a powerful tool to investigate protein-protein interactions (PPIs) in living cells. However, non-specific association of the fluorescent protein fragments in a BiFC system can complicate evaluation of PPIs. Here, we introduced a bicistronic expression vector, pBudCE4.1, into an mLumin-based BiFC system, denoted as the BEVL-BiFC system. The BEVL-BiFC system achieved a 25-fold contrast in BiFC efficiency between positive (Fos/Jun) and negative (ΔFos/Jun) PPIs. The high BiFC efficiency was due to a low false-positive rate, where less than 2% of cells displayed BiFC in the negative control. K-Ras and its interactive proteins, Ras binding domain (RBD) of Raf-1 and Grb2 were used to confirm the accuracy of the BEVL-BiFC system. The results also provide direct evidence in individual cells that post-translational modification of K-Ras and its localization at the plasma membrane (PM) were not essential for the interaction of K-Ras and Raf-1, whereas the interaction of Grb2 and K-Ras did depend on the PM localization of K-Ras. Taken together, the BEVL-BiFC system was developed to reduce the false-positive phenomenon in BiFC assays, resulting in more robust and accurate measurement of PPIs in living cells.
双分子荧光互补(BiFC)检测法简单而灵敏,是研究活细胞内蛋白质-蛋白质相互作用(PPIs)的有力工具。然而,BiFC 系统中荧光蛋白片段的非特异性结合会使 PPI 的评估变得复杂。在这里,我们将一个双顺反子表达载体 pBudCE4.1 引入到基于 mLumin 的 BiFC 系统中,称为 BEVL-BiFC 系统。BEVL-BiFC 系统在阳性(Fos/Jun)和阴性(ΔFos/Jun)PPIs 之间实现了 25 倍的 BiFC 效率对比。高 BiFC 效率归因于低假阳性率,阴性对照中只有不到 2%的细胞显示 BiFC。K-Ras 及其相互作用蛋白、Raf-1 的 Ras 结合域(RBD)和 Grb2 被用来验证 BEVL-BiFC 系统的准确性。结果还在单个细胞中提供了直接证据,表明 K-Ras 的翻译后修饰及其在质膜(PM)上的定位对于 K-Ras 和 Raf-1 的相互作用不是必需的,而 Grb2 和 K-Ras 的相互作用确实依赖于 K-Ras 的 PM 定位。总之,BEVL-BiFC 系统的开发是为了减少 BiFC 检测中的假阳性现象,从而更稳健、更准确地测量活细胞内的 PPI。